🔎 Trials Near Me

ホーム › 非小細胞肺癌 › ルイジアナ州

ルイジアナ州における非小細胞肺癌の臨床試験

ルイジアナ州内の拠点で、非小細胞肺癌に関する26件の研究が参加者を募集しています。

ルイジアナ州内の都市

公式研究テキスト(英語)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

  • Christus Saint Frances Cabrini Hospital, Alexandria
  • LSU Health Baton Rouge-North Clinic, Baton Rouge
  • Our Lady of the Lake Physician Group, Baton Rouge
  • 他11件
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT04267848

Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

  • Pontchartrain Cancer Center - Covington Office, Covington
  • Pontchartrain Cancer Center - Hammond Office, Hammond
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06472245

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

  • University Medical Center New Orleans, New Orleans
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06498635

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

  • LSU Health Baton Rouge North Clinic ( Site 4003), Baton Rouge
  • Our Lady of the Lake Physician Group-Medical Oncology ( Site 0080), Baton Rouge
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06312137

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

  • Pontchartrain Cancer Center, Covington
  • Pontchartrain Cancer Center, Hammond
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07222566

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

  • Mary Bird Perkins Cancer Center, Baton Rouge
  • Ochsner Health Ochsner Cancer Center - Baton Rouge, Baton Rouge
  • Ochsner Clinic Foundation, New Orleans
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/24更新 · NCT06890598

Pan-tumor MRD Study

  • Pontchartrain Cancer Center, Covington
  • Christus Health Highlands, Shreveport
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/24更新 · NCT06605404

Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC

  • Our Lady of the Lake Physician's Group, Baton Rouge
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/21更新 · NCT06745882

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

  • Mary Bird Perkins Cancer Center, Baton Rouge
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/21更新 · NCT07629960

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

  • Research Site, Baton Rouge
  • Research Site, Shreveport
  • Research Site, Shreveport
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/18更新 · NCT06692738

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

  • Clinical Study Site, Covington
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/18更新 · NCT06767514

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

  • Local Institution - 007-994-A, Covington
  • Pontchartrain Cancer Center - Covington Office, Covington
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/16更新 · NCT04613596

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

  • Tulane Cancer Center, New Orleans
  • Christus Highland/ Boniol, Shreveport
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/14更新 · NCT05059444

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • Mary Bird Perkins Cancer Center, Baton Rouge
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT06119581

A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors

  • LSU Health Sciences Center School of Medicine, New Orleans
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/04更新 · NCT07361562

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  • Local Institution - 2116, New Orleans
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/05/27更新 · NCT03093116

Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)

  • Tulane Cancer Center, New Orleans
被験者募集中第3相
18歳以上 · 全性別 · 2026/05/19更新 · NCT07154706

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

  • Ochsner Health, Jefferson
被験者募集中第1相
18歳以上 · 全性別 · 2026/05/18更新 · NCT07094204

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

  • Mary Bird Perkins Cancer Center, Baton Rouge
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/05/15更新 · NCT05379985

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

  • Ochsner LSU Health Monroe Medical Center, Monroe
  • LSU Health Sciences Center at Shreveport, Shreveport
被験者募集中観察研究
18歳以上 · 全性別 · 2026/03/17更新 · NCT06418204

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, New Orleans
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774

A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs

  • Ochsner/MD Anderson Cancer Center, New Orleans
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/10/24更新 · NCT06228326

Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors

  • University Medical Center - New Orleans, New Orleans
被験者募集中第1相
18歳以上 · 全性別 · 2025/10/10更新 · NCT06784193

Utilizing Long-read Sequencing to Investigate the EGFR Landscape of EGFR Positive Lung Cancer Patients

  • Our Lady of the Lake Regional Medical Center, Baton Rouge
被験者募集中観察研究健康なボランティア歓迎
18歳〜100歳 · 女性 · 2025/03/20更新 · NCT06659458

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。